Molbio Diagnostics shares rose over 5% on October 1, after HDFC Mutual Fund acquired a 1.99% stake. The stock gained approximately 71% since its IPO, and Jefferies assigned a ‘Buy’ rating, setting a target price of ₹1,600, indicating over 98% upside potential.
Molbio Diagnostics shares rose over 5% on October 1, after HDFC Mutual Fund acquired a 1.99% stake. The stock gained approximately 71% since its IPO, and Jefferies assigned a ‘Buy’ rating, setting a target price of ₹1,600, indicating over 98% upside potential.
<iframe src="https://hindustansphere.com/embed/cluster/f30987f2b05c5df49bdcda14e77897d991ff0dfd" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Molbio Diagnostics shares jump 5% as HDFC MF buys 1.99% stake via bulk deal | Newly listed stock up 71% from IPO price"></iframe>
